TB-500 is an acetylated synthetic peptide corresponding to a short region of the protein thymosin beta-4. It is supplied here as a lyophilised powder in a sealed vial.
This listing is for the compound as an analytical and research material. No application, effect or property in humans or animals is stated or implied.
Background
Thymosin beta-4 is a naturally occurring protein of 43 amino acids. TB-500 is the synthetic, acetylated fragment corresponding to a specific region within that sequence, produced by solid-phase peptide synthesis rather than isolated from biological material.
It is not a licensed medicine in the United Kingdom and holds no marketing authorisation. It is not a controlled substance under the Misuse of Drugs Act 1971.
For structural detail, published literature and citations, see the compound reference entry: /compounds/tb-500-10mg/
There are no reviews yet.